ACR Convergence 2026

November 6-11, 2026. Orlando, Florida.

View by Number View by Title View Sessions

Abstract Number: 0017

Spatial Mapping of Synovial Immune Architecture Identifies an Enriched Tfh Niche in Rheumatoid Arthritis
Abstract Number: 0018

TGF β1/Smad3/IL 9 Axis Drives Inflammation in Gout: A Novel Pro inflammatory Pathway and Potential Therapeutic Target
Abstract Number: 0019

TL1A and TL1A-Driven Inflammatory and Fibrosis Pathways are Upregulated in Sarcoidosis
Abstract Number: 0020

TLR2 Drives Pathogenic CD8⁺ T Cell Activation Through Metabolic Reprogramming in Sjögren’s Disease
Abstract Number: 0021

Weak Endogenous Antigen Encounter Reveals a TCR Signaling Threshold for Peripheral Tolerance
Abstract Number: 0022

A Novel HDAC6 Deacetylase Inhibitor Elongates Primary Cilia in Fibroblasts: Ciliotherapy for Fibrosis
Abstract Number: 0023

Anti-CD206 CAR T Cell Immunotherapy Ameliorates Fibrosis
Abstract Number: 0024

Cross-Tissue and Compartmental Single-Cell Profiling Validates PDE4B as a Potential Therapeutic Target in Systemic Sclerosis
Abstract Number: 0025

Defining Molecular Drivers of Progressive Pulmonary Fibrosis in Systemic Autoimmune Rheumatic Disease
Abstract Number: 0026

Defining the role of TEADs and VGLL3 in scleroderma endothelial cells
Abstract Number: 0027

Delineating m6A RNA methylation in systemic sclerosis identifies demethylase FTO as a therapeutic target for fibrosis
Abstract Number: 0028

Divergent Roles for Classical and Non-Classical Monocytes in the Development of a Multi-Organ Murine Model of Systemic Sclerosis
Abstract Number: 0029

Generation, Viability Assessment and Fibrotic Transformation of a Novel Organotypic Model for Cutaneous Fibrosis: Basis for Therapeutic Optimization in Systemic Sclerosis
Abstract Number: 0030

Genetic prediction of systemic sclerosis and its subphenotypes using joint HLA and polygenic risk score models
Abstract Number: 0031

High-throughput plasma proteomics reveals circulating biomarkers of interstitial lung disease and progressive pulmonary fibrosis in systemic sclerosis